These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 29136524)
1. Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium. Zou T; Lok CN; Wan PK; Zhang ZF; Fung SK; Che CM Curr Opin Chem Biol; 2018 Apr; 43():30-36. PubMed ID: 29136524 [TBL] [Abstract][Full Text] [Related]
2. Metal-N-heterocyclic carbene complexes as anti-tumor agents. Hu C; Li X; Wang W; Zhang R; Deng L Curr Med Chem; 2014 Apr; 21(10):1220-30. PubMed ID: 24350852 [TBL] [Abstract][Full Text] [Related]
3. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs. Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266 [TBL] [Abstract][Full Text] [Related]
4. New insights in Au-NHCs complexes as anticancer agents. Porchia M; Pellei M; Marinelli M; Tisato F; Del Bello F; Santini C Eur J Med Chem; 2018 Feb; 146():709-746. PubMed ID: 29407992 [TBL] [Abstract][Full Text] [Related]
5. A Patil S; P Hoagland A; A Patil S; Bugarin A Future Med Chem; 2020 Dec; 12(24):2239-2275. PubMed ID: 33228391 [No Abstract] [Full Text] [Related]
6. Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets. Fung SK; Zou T; Cao B; Lee PY; Fung YM; Hu D; Lok CN; Che CM Angew Chem Int Ed Engl; 2017 Mar; 56(14):3892-3896. PubMed ID: 28247451 [TBL] [Abstract][Full Text] [Related]
7. The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer. Scattolin T; Bortolamiol E; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Cavallo L; Dereli B; Mane MV; Nolan SP; Visentin F Chem Commun (Camb); 2020 Oct; 56(81):12238-12241. PubMed ID: 32926011 [TBL] [Abstract][Full Text] [Related]
8. Novel cis-[(NHC) Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959 [TBL] [Abstract][Full Text] [Related]
9. Direct functionalisation of group 10 N-heterocyclic carbene complexes for diversity enhancement. Chardon E; Puleo GL; Dahm G; Guichard G; Bellemin-Laponnaz S Chem Commun (Camb); 2011 May; 47(20):5864-6. PubMed ID: 21503314 [TBL] [Abstract][Full Text] [Related]
11. N-Heterocyclic carbene metal complexes in medicinal chemistry. Oehninger L; Rubbiani R; Ott I Dalton Trans; 2013 Mar; 42(10):3269-84. PubMed ID: 23223752 [TBL] [Abstract][Full Text] [Related]
12. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators. Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, structures, and selective toxicity to cancer cells of gold(I) complexes involving N-heterocyclic carbene ligands. Boselli L; Ader I; Carraz M; Hemmert C; Cuvillier O; Gornitzka H Eur J Med Chem; 2014 Oct; 85():87-94. PubMed ID: 25078312 [TBL] [Abstract][Full Text] [Related]
14. Stable N-heterocyclic carbene (NHC)-palladium(0) complexes as active catalysts for olefin cyclopropanation reactions with ethyl diazoacetate. Martín C; Molina F; Alvarez E; Belderrain TR Chemistry; 2011 Dec; 17(52):14885-95. PubMed ID: 22139750 [TBL] [Abstract][Full Text] [Related]
15. Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression. Fong TT; Lok CN; Chung CY; Fung YM; Chow PK; Wan PK; Che CM Angew Chem Int Ed Engl; 2016 Sep; 55(39):11935-9. PubMed ID: 27571430 [TBL] [Abstract][Full Text] [Related]
16. N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes. Maftei CV; Fodor E; Jones PG; Freytag M; Franz MH; Kelter G; Fiebig HH; Tamm M; Neda I Eur J Med Chem; 2015 Aug; 101():431-41. PubMed ID: 26185007 [TBL] [Abstract][Full Text] [Related]
17. Caffeine-based gold(I) N-heterocyclic carbenes as possible anticancer agents: synthesis and biological properties. Bertrand B; Stefan L; Pirrotta M; Monchaud D; Bodio E; Richard P; Le Gendre P; Warmerdam E; de Jager MH; Groothuis GM; Picquet M; Casini A Inorg Chem; 2014 Feb; 53(4):2296-303. PubMed ID: 24499428 [TBL] [Abstract][Full Text] [Related]
18. Cyclometalated gold(III) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons. Yan JJ; Chow AL; Leung CH; Sun RW; Ma DL; Che CM Chem Commun (Camb); 2010 Jun; 46(22):3893-5. PubMed ID: 20401423 [TBL] [Abstract][Full Text] [Related]
19. Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents. Zou T; Lum CT; Chui SS; Che CM Angew Chem Int Ed Engl; 2013 Mar; 52(10):2930-3. PubMed ID: 23371740 [No Abstract] [Full Text] [Related]
20. Fluorinated-NHC Transition Metal Complexes: Leading Characters as Potential Anticancer Metallodrugs. Rufino-Felipe E; Colorado-Peralta R; Reyes-Márquez V; Valdés H; Morales-Morales D Anticancer Agents Med Chem; 2021; 21(8):938-948. PubMed ID: 32900353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]